(Q3869873)

English

nafarelin

pharmaceutical drug

Statements

0 references
Nafarelin.svg
512 × 315; 114 KB
0 references
1,321.635626±0 dalton
1 reference
C₆₆H₈₃N₁₇O₁₃
1 reference
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC=CC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8
0 references
CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@H](CC6=CNC=N6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N8CCC[C@H]8C(=O)NCC(N)=O

Identifiers

0 references
686-425-8
1 reference
27 December 2018
[No public or meaningful name is available] (English)
CAS no.: 76932-56-4 (English)
1 reference
27 December 2018
[No public or meaningful name is available] (English)
CAS no.: 76932-56-4 (English)
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit